Jane Sarasohn
Jane has a knack for understanding how technology will change the future of health care. She combines her expertise in business and economics with insights from social sciences, medicine, and other fields to help organizations anticipate changes that could affect their strategy or operations. Jane’s work spans healthcare stakeholders – patients, providers (hospitals/health systems), payers (insurance companies), suppliers like device manufacturers.
The Health Populi blog is now updated twice-weekly by Jane’s team at Deloitte Consulting LLP, where she advises clients on emerging trends related to people, technology, and health policy.
Jane’s career spans many different fields of expertise: she is an international speaker with talks ranging from “The Future of Healthcare” to “How Technology Impacts Patient Care.”
If you’ve ever wondered where we are headed with our advancements in medical science or if there could be some potential problems down the line like shortages due to automation…Jane might have answers for you!
Jane Sarasohn Articles
Trust is a Superpower for Public Health – The 2024 Edelman Trust Barometer Through the Health Lens
Less than 50% of people living in 16 countries do not trust government, media, or NGOs to do what is…
Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 2
17This post follows up Part 1 of this two-part series I’ve prepared in advance of the AHIP 2024 conference where…
Healthcare 2030: Are We Consumers, CEOs, Health Citizens, or Castaways? 4 Scenarios On the Future of Health Care and Who We Are – Part 1
In the past few years, what event or innovation has had the metaphorical impact of hitting you upside the head…
A Vote for Telehealth is a Vote for American Patients’ and Doctors’ Well-Being
Whether you’re a patient or a physician in the U.S., you’re burned out, tapped out, stressed out, timed out. While…
Considering Equity and Consumer Impacts of GLP-1 Drugs – A UBS Economist Weighs In
Since the introduction of GLP-1 drugs on the market, their use has split into two categories: for obesity and “recreationally,”…
A Springtime Re-Set for Self-Care, From Fitness to Cozy Cardio: Peloton’s Latest Consumer Research
How many people do you know that don’t know their cholesterol or their BMI, their net worth or IQ, their…
Safety in Health Care Ties Closely to Workforce Well-Being – Updates from Press Ganey and ECRI
“First, do no harm” is a key M.O. in health care. The phrase “patient safety” summons up a list of…
Consumers Are So Over Their Paper Chase in Health Care Payments
As we start the month of April 2024 in the U.S., it’s tax season in America with Federal (and other)…
The Self-Prescribing Consumer: DIY Comes to Prescriptions via GLP-1s, the OPill, and Dexcom’s CGM
Three major milestones marked March 2024 which compel us to note the growing role of patients-as-consumers — especially for self-prescribing…